Descriptor English: | Emtricitabine, Rilpivirine, Tenofovir Drug Combination | ||||
Descriptor Spanish: |
Combinación Emtricitabina, Rilpivirina y Tenofovir
| ||||
Descriptor Portuguese: | Combinação Emtricitabina, Rilpivirina e Tenofovir | ||||
Descriptor French: | Association d'emtricitabine, de rilpivirine et de ténofovir | ||||
Entry term(s): |
Combination, Emtricitabine-Rilpivirine-Tenofovir Drug Complera Drug Combination, Emtricitabine-Rilpivirine-Tenofovir Emtricitabine Rilpivirine Tenofovir Drug Combination Emtricitabine-Rilpivirine-Tenofovir Drug Combination |
||||
Tree number(s): |
D02.626.809.500 D02.705.429.906.500 D03.383.742.680.245.500.600.500 D03.383.742.755.500 D03.633.100.759.138.881.500 D26.310.407 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068678 | ||||
Scope note: | A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antiviral Agents Reverse Transcriptase Inhibitors Anti-HIV Agents |
||||
Public MeSH Note: | 2016; EMTRICITABINE, RILPIVIRINE, TENOFOVIR DRUG COMBINATION was indexed under NITRILES; PYRIMIDINES; ORGANOPHOSPHONATES; ADENINE; and DEOXYCYTIDINE 2012-2015 |
||||
History Note: | 2016 (2012) |
||||
DeCS ID: | 55898 | ||||
Unique ID: | D000068678 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations
|
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
- Preferred
Complera
- Narrower
Concept UI |
M000603524 |
Scope note | A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. |
Preferred term | Emtricitabine, Rilpivirine, Tenofovir Drug Combination |
Entry term(s) |
Combination, Emtricitabine-Rilpivirine-Tenofovir Drug Drug Combination, Emtricitabine-Rilpivirine-Tenofovir Emtricitabine Rilpivirine Tenofovir Drug Combination Emtricitabine-Rilpivirine-Tenofovir Drug Combination |
Concept UI |
M0573815 |
Preferred term | Complera |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey